Astal Laboratories (BOM:512600) Total Operating Expense: ₹50 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:512600 Astal Laboratories Ltd BOM:512600
48 GF Score
Price ₹82.55
GF Value ₹52.99
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Astal Laboratories Total Operating Expense?

Astal Laboratories BOM:512600 +2.62% 48 Total Operating Expense is ₹50 Mil as of Mar. 2026. GuruFocus rates BOM:512600 with a GF Score™ of 48/100 and a GF Value™ of ₹52.99 (Significantly Overvalued). The stock has 8 warning signs investors should review.

Astal Laboratories's Total Operating Expense for the three months ended in Mar. 2026 was ₹16 Mil. Astal Laboratories's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹50 Mil.

Astal Laboratories Total Operating Expense Related Terms

Astal Laboratories Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Astal Laboratories's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Astal Laboratories Total Operating Expense Chart

Astal Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.20 2.20 12.24 35.66 50.43

Astal Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.34 8.23 9.50 16.82 15.88
BOM:512600
48GF Score
Astal Laboratories Ltd BOM:512600
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Astal Laboratories Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹50 Mil mean?
Astal Laboratories (BOM:512600) has a Total Operating Expense of ₹50 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Astal Laboratories and its competitors.
Is Astal Laboratories' Total Operating Expense too high?
Astal Laboratories' current Total Operating Expense is ₹50 Mil. Overall, Astal Laboratories has a GF Score™ of 48/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Astal Laboratories' Total Operating Expense compare to ZTS and UTHR?
Astal Laboratories' Total Operating Expense of ₹50 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Astal Laboratories and its competitors. Astal Laboratories's current Total Operating Expense is ₹50 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Astal Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Astal Laboratories (BOM:512600) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹52.99, compared to a current price of ₹82.55 — trading 55.8% above its estimated fair value. The current Total Operating Expense is ₹50 Mil. Astal Laboratories' overall GF Score™ is 48/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Astal Laboratories (BOM:512600), the current Total Operating Expense is ₹50 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Astal Laboratories (BOM:512600) Overvalued in 2026?

Based on GuruFocus' analysis, Astal Laboratories stock appears to be overvalued. The current stock price of ₹82.55 is trading 55.8% above its estimated GF Value™ of ₹52.99. GuruFocus considers Astal Laboratories to be Significantly Overvalued.

Key valuation signals for BOM:512600:

  • Total Operating Expense: ₹50 Mil
  • GF Value™: ₹52.99 vs. price of ₹82.55 (55.8% above fair value)
  • GF Score™: 48/100 with 8 warning signs

No single metric tells the full story. See the BOM:512600 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Astal Laboratories Business Description

Address D-1, Motilal Atal Road, Behind Hotel Neelam, Jaipur, RJ, IND, 302001
Astal Laboratories Ltd is an India-based company. The main objects of the company are to manufacture and sales of Pharmaceutical Intermediates and Bulk Drugs. The company has a single segment, i.e., Pharmaceuticals.
48GF Score

Get the complete analysis for BOM:512600

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹82.55
Price
₹52.99
GF Value